Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.418ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.418ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.418EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.418EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.418ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.418ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.9.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.9.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.9.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.9.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.9.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.9.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.9.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.9.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.40EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.40EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.40ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.40ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.40EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.40EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.40ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.40ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.16.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.1.16.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.16.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.1.16.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.1.16.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.1.16.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.1.16.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.16.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DN.1.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
DN.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DN.1.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
DN.1.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
DN.1.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
DN.1.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
DN.1.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DN.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.160.28EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.160.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.28ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.160.28ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.160.28EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.160.28EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.160.28ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.160.28ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.5.2 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.5.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.5.2 (Delta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.5.2 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used